4
Changes in Ownership
Nuvectis Pharma, Inc. Filed Acc 0001104659-24-060262
Chief Science & Business Off bought 500 shares at $6.29 ($3,145)
From the SEC's structured data for this filing
Trades in this filing
Poradosu Enrique · Chief Science & Business Off
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-05-10 | Purchase : show line 1 in the form | +500 | $6.29 | $3,145 | 1,504,319 | D |
| Open-market purchases · 500 sh · avg $6.29 · $3,145 | ||||||
Loading xslF345X05/tm2414233-2_4seq1.xml…